Related Experiment Video
Updated: Jan 20, 2026
09:06
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
1.9K
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Federica Miglietta1,2, Gaia Griguolo1,2, Valentina Guarneri3,2
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
The Oncologist
|August 25, 2019
Summary
Programmed cell death ligand 1 (PD-L1) shows promise as a biomarker for breast cancer immunotherapy. Further research is needed to clarify its prognostic and predictive roles and address technical challenges for clinical use.
Area of Science:
- Oncology
- Immunology
- Biomarker Research
Background:
- Immunotherapy, particularly immune checkpoint inhibitors, offers a promising treatment strategy for breast cancer (BC), especially the triple-negative subtype.
- However, only a subset of patients benefits, necessitating reliable biomarkers for patient selection.
- Programmed cell death ligand 1 (PD-L1) has emerged as a potential biomarker with controversial findings regarding its prognostic and predictive value.
Purpose of the Study:
- To review the biological relevance and clinical utility of PD-L1 expression in breast cancer.
- To critically evaluate the prognostic and predictive implications of PD-L1.
- To highlight technical aspects and methodological pitfalls impacting PD-L1 implementation.
Main Methods:
- Comprehensive literature review of studies investigating PD-L1 in breast cancer.
- Analysis of evidence on PD-L1's biological function and clinical performance.
- Examination of technical considerations in PD-L1 assessment.
Main Results:
- PD-L1 expression is intensively explored as a biomarker in breast cancer, yielding controversial results.
- Evidence suggests potential prognostic and predictive roles, but clinical utility is hampered by technical variability.
- Understanding these technical aspects is crucial for optimizing PD-L1's application.
Conclusions:
- PD-L1 holds potential as a biomarker to guide breast cancer immunotherapy selection.
- Standardization of PD-L1 assessment methods is essential for reliable clinical application.
- Further research is required to fully elucidate PD-L1's role and overcome implementation challenges.
Related Concept Videos
02:27Predicting Products: SN1 vs. SN2
15.9K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
15.9K
01:30Overview of Cell Death
9.5K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.5K
01:18Autophagic Cell Death
4.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.4K
02:40Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
00:49Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
02:51Metal-Ligand Bonds
24.0K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.0K